Your browser doesn't support javascript.
Factors Associated with Adverse Reactions to BNT162b2 COVID-19 Vaccine in a Cohort of 3969 Hospital Workers.
Rivera-Izquierdo, Mario; Soler-Iborte, Eva; de Rojas, Javier Pérez; Pegalajar-García, María Dolores; Gil-Villalba, Ana; Ruiz-Villaverde, Ricardo; Valero-Ubierna, María Del Carmen.
  • Rivera-Izquierdo M; Service of Preventive Medicine and Public Health, Hospital Universitario San Cecilio, 18016 Granada, Spain.
  • Soler-Iborte E; Department of Preventive Medicine and Public Health, Hospital Universitario San Cecilio, 18016 Granada, Spain.
  • de Rojas JP; Instituto Biosanitario de Granada (ibs.GRANADA), 18012 Granada, Spain.
  • Pegalajar-García MD; Service of Preventive Medicine and Public Health, Hospital Universitario San Cecilio, 18016 Granada, Spain.
  • Gil-Villalba A; Service of Preventive Medicine and Public Health, Hospital Universitario San Cecilio, 18016 Granada, Spain.
  • Ruiz-Villaverde R; Service of Dermatology, Hospital Universitario San Cecilio, 18016 Granada, Spain.
  • Valero-Ubierna MDC; Service of Dermatology, Hospital Universitario San Cecilio, 18016 Granada, Spain.
Vaccines (Basel) ; 10(1)2021 Dec 23.
Article in English | MEDLINE | ID: covidwho-1580362
ABSTRACT
Factors associated with adverse reactions to BNT162b2 COVID-19 vaccine reported by hospital workers are unclear. Our aim was to collect all reported adverse events in a cohort of hospital workers and to analyze the factors associated with their presence. We conducted an observational longitudinal study on all hospital workers of our center who received COVID-19 vaccination from 27 December 2020 to 1 September 2021. Information on adverse events was reported telephonically and confirmed through clinical records. Chi-square and t tests as well as multivariate logistic regression models were used. Cluster analysis was designed to explore associations between reactions. A total of 3969 hospital workers were included in the sample. Of the total sample, 182 workers (4.6%) reported adverse events. The most frequent symptoms were general malaise (n = 95), fever (n = 92), arthromyalgia (n = 80), and headache (n = 47). The factors associated with adverse events in adjusted analyses were an antecedent of COVID-19 infection (OR = 2.09, 95% CI 1.47-2.98), female sex (OR = 1.51, 95% CI 1.03-2.20), and professional category (OR for physicians = 0.41, 95% CI 0.21-0.80). We report a low frequency of adverse events in hospital workers after COVID-19 vaccination and no severe reaction. Men and physicians underreported their symptoms. These data should guide future strategies for recording adverse events and future research on COVID-19 vaccination safety.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines10010015

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines10010015